HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 58 filers reported holding HOOKIPA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39 | -30.4% | 64 | 0.0% | 0.00% | – |
| Q2 2023 | $56 | +19.1% | 64 | 0.0% | 0.00% | – |
| Q1 2023 | $47 | -90.8% | 64 | -89.8% | 0.00% | – |
| Q4 2022 | $509 | – | 628 | +881.2% | 0.00% | – |
| Q3 2022 | $0 | – | 64 | +14.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 56 | -96.6% | 0.00% | – |
| Q1 2022 | $4,000 | -82.6% | 1,648 | -83.2% | 0.00% | – |
| Q4 2021 | $23,000 | +27.8% | 9,833 | +219.1% | 0.00% | – |
| Q3 2021 | $18,000 | -53.8% | 3,081 | -28.4% | 0.00% | – |
| Q2 2021 | $39,000 | -26.4% | 4,302 | +10.0% | 0.00% | – |
| Q1 2021 | $53,000 | +140.9% | 3,912 | +95.0% | 0.00% | – |
| Q4 2020 | $22,000 | +1000.0% | 2,006 | +722.1% | 0.00% | – |
| Q3 2020 | $2,000 | -95.9% | 244 | -94.2% | 0.00% | – |
| Q2 2020 | $49,000 | -35.5% | 4,223 | -54.3% | 0.00% | – |
| Q1 2020 | $76,000 | -55.8% | 9,248 | -34.1% | 0.00% | – |
| Q4 2019 | $172,000 | +514.3% | 14,028 | +277.8% | 0.00% | – |
| Q3 2019 | $28,000 | +115.4% | 3,713 | +89.0% | 0.00% | – |
| Q2 2019 | $13,000 | – | 1,965 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
| Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
| Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
| HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
| DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
| Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
| HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
| Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |